Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Paul Bisaro
Pharma
Mallinckrodt faces lawsuit for allegedly misleading investors
Mallinckrodt investors have filed a class action lawsuit, accusing the company of making false and misleading statements about its financial health.
Kevin Dunleavy
Jul 14, 2023 10:10am
Amneal chairman Paul Bisaro, CEO exit in leadership shakeup
Aug 5, 2019 12:00pm
Allergan architect Bisaro exits board as revamp continues
Aug 30, 2018 11:11am
Impax, retailers ink midtrial Solodyn settlement
Mar 27, 2018 10:08am
Impax sells Taiwan plant, strikes Rytary supply deal with Bora
Jan 3, 2018 11:53am
Bisaro, Amneal poach top Allergan exec for CEO's chair
Dec 18, 2017 12:23pm
